Elektrofi is a Biotech company based in Boston. It has raised $152M in total funding. Latest round: Series C.
Elektrofi funding overview
Elektrofi is a Biotech company based in Boston. Elektrofi has raised $152M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series C announced in January 2024. The round record for Elektrofi runs through 2024; nothing later has been disclosed. Investors on record include Novo Holdings, Marshall Wace, BVF Partners, Janus Henderson Investors, Logos Capital. 5 distinct backers are named across the disclosed rounds.
Elektrofi at a glance
Total raised
$152M
Latest round
Series C
Latest round date
January 2024
Industry
Biotech
Headquarters
Boston
Notable investors
Novo Holdings, Marshall Wace, BVF Partners, Janus Henderson Investors, Logos Capital
Frequently asked about Elektrofi funding
How much has Elektrofi raised?
Elektrofi has raised $152M in total disclosed funding across the rounds on record.
Who has invested in Elektrofi?
Novo Holdings, Marshall Wace, BVF Partners, Janus Henderson Investors, Logos Capital are named among the investors backing Elektrofi.
What was the latest Elektrofi funding round?
The most recent disclosed round is a Series C, announced in January 2024.
Where is Elektrofi based?
Elektrofi is based in Boston.
What sector does Elektrofi operate in?
Elektrofi is tracked under Biotech from Boston, with $152M in disclosed funding.
When did Elektrofi last raise?
The last disclosed Elektrofi round closed in January 2024 at Series C.
Round data for Elektrofi is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Boston and backer lists below.
